Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Not applicableStudy completedNCT04153227
What this trial is testing

Osteoporosis, Trabecular Bone Score and Fracture Risk Assessment in Male Patients After Radical Cystectomy

Who this might be right for
OsteoporosisBladder Disease
Corporacion Parc Tauli 112
Testing effectiveness (Phase 2)Study completedNCT04507061
What this trial is testing

Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.

Who this might be right for
Chronic Kidney Disease
Bayer 243
Testing effectiveness (Phase 2)Ended earlyNCT02010203
What this trial is testing

HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Who this might be right for
Bladder Cancer
Heat Biologics 104
Early research (Phase 1)Study completedNCT00814086
What this trial is testing

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more
Gynecologic Oncology Group 23
Early research (Phase 1)Study completedNCT05429073
What this trial is testing

RGLS8429 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Regulus Therapeutics Inc. 32
Testing effectiveness (Phase 2)Ended earlyNCT02626754
What this trial is testing

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Who this might be right for
Renal Cell Carcinoma
vghtpe user 13
Early research (Phase 1)Study completedNCT02502903
What this trial is testing

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

Who this might be right for
Bullous Pemphigoid (BP)Cold Agglutinin Disease (CAD)Warm Autoimmune Hemolytic Anemia (WAIHA)+1 more
Bioverativ, a Sanofi company 122
Early research (Phase 1)Study completedNCT03237988
What this trial is testing

Study to Evaluate the Pharmacokinetics of a New Tablet Formulation of CPI-444 in Fed and Fasted Healthy Male and Female Subjects

Who this might be right for
Healthy Subjects
Corvus Pharmaceuticals, Inc. 24
Post-approval studies (Phase 4)Study completedNCT00006170
What this trial is testing

Bupropion and Weight Control for Smoking Cessation - 1

Who this might be right for
Tobacco Use Disorder
University of Pittsburgh 349
Early research (Phase 1)Study completedNCT05363215
What this trial is testing

Assess S-217622 in Participants With Renal Impairment and Healthy Participants

Who this might be right for
Renal Impairment
Shionogi 32
Not applicableUnknownNCT03158649
What this trial is testing

A Novel Web-based Positive Psychology Intervention Addressed to Pregnant Women

Who this might be right for
PregnancyMental Health Wellness 1
University of Valencia 164
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Early research (Phase 1)Study completedNCT03174548
What this trial is testing

Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects

Who this might be right for
Diabetes Mellitus
Sanofi 14
Early research (Phase 1)Study completedNCT01478685
What this trial is testing

CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellOvarian Neoplasms+5 more
Celgene 169
Not applicableNot Yet RecruitingNCT07313085
What this trial is testing

Mechanisms of Fecal Incontinence in Wolfram Syndrome

Who this might be right for
Wolfram SyndromeFecal Incontinence
Hôpital Necker-Enfants Malades 20
Testing effectiveness (Phase 2)Study completedNCT05198804
What this trial is testing

Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian CancerPlatinum-resistant Ovarian CancerPrimary Peritoneal Carcinoma+1 more
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 117
Not applicableLooking for participantsNCT06338072
What this trial is testing

Impact of the Menstrual Cycle in Reproductive Aged Women With Type 1 Diabetes Using a Closed Loop System (DIABETEXX/1).

Who this might be right for
Type 1 Diabetes
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 119
Early research (Phase 1)Study completedNCT05955872
What this trial is testing

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 21
Large-scale testing (Phase 3)Study completedNCT03924856
What this trial is testing

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 907
Next Page